Jane Street’s Sanara MedTech SMTI Stock Holding History

Jane Street’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.2M	Buy	50,806 +12,222	+32%	+$253K	﹤0.01%	6154
2026 Q1	$663K	Buy	38,584 +23,367	+154%	+$481K	﹤0.01%	7382
2025 Q4	$355K	Buy	+15,217	New	+$393K	﹤0.01%	8452
2023 Q2	–	Sell	-17,594	Closed	-$726K	–	9510
2023 Q1	$726K	Buy	+17,594	New	+$742K	﹤0.01%	5647

Other funds holding SMTI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

SWM

Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Jane Street's SMTI Position: Q2 2026 in Review

Jane Street increased its Sanara MedTech (SMTI) stake by 32% in Q2 2026, buying an estimated $253K and bringing the position to 50,806 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #6154.

Jane Street first reported a position in SMTI in Q1 2023 and has held it in 4 quarters since. 75 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

Jane Street held 50,806 shares of Sanara MedTech worth $1.2M as of Q2 2026.
Jane Street bought 12,222 Sanara MedTech shares in Q2 2026, an estimated $253K.
Sanara MedTech made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #6154 holding.
Jane Street first reported a position in Sanara MedTech in Q1 2023 and has held it in 4 quarters since.
75 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.